Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors

Daniel Hind, Myfanwy Lloyd-Jones, Michael Makris, Suzy Paisley

Open source

DOI
10.1002/14651858.cd004449.pub2
Published
2004-04-19
Container
Cochrane Database of Systematic Reviews
Publisher
John Wiley & Sons, Ltd
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/14651858.cd004449.pub2,
  title = {Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors},
  author = {Daniel Hind and Myfanwy Lloyd-Jones and Michael Makris and Suzy Paisley},
  year = {2004},
  journal = {Cochrane Database of Systematic Reviews},
  doi = {10.1002/14651858.cd004449.pub2},
  url = {https://doi.org/10.1002/14651858.cd004449.pub2}
}

RIS

TY  - JOUR
TI  - Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors
AU  - Daniel Hind
AU  - Myfanwy Lloyd-Jones
AU  - Michael Makris
AU  - Suzy Paisley
PY  - 2004
JO  - Cochrane Database of Systematic Reviews
DO  - 10.1002/14651858.cd004449.pub2
UR  - https://doi.org/10.1002/14651858.cd004449.pub2
ER  - 

APA

Hind, D., Lloyd-Jones, M., Makris, M., & Paisley, S. (2004). Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd004449.pub2

Source records